CG Sep 2024 45.000 call
| Previous close | 1.3000 |
| Open | 1.5000 |
| Bid | 1.3500 |
| Ask | 1.4500 |
| Strike | 45.00 |
| Expiry date | 2024-09-20 |
| Day's range | 1.4200 - 1.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 178 |
ZacksAfter Plunging -13.6% in 4 Weeks, Here's Why the Trend Might Reverse for Carlyle (CG)
Carlyle (CG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
BloombergPro-Gest Talks to Carlyle, Cheyne to Extend Debt and Get Funds
(Bloomberg) -- Pro-Gest SpA’s talks with creditors including Carlyle Group Inc. and Cheyne Capital are intensifying as the Italian packaging company seeks to manage looming debt maturities and raise new funds.Most Read from BloombergSaudi Arabia Steps Up Arrests Of Those Attacking Israel OnlineApple Rallies on Upbeat Forecast, Record-Setting BuybackTurkey Confirms All Trade Halt With Israel Over War in GazaHuawei Secretly Backs US Research, Awarding Millions in PrizesTrump Auditions VP Picks Bef
GlobeNewswireAcentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission
Verlon Johnson Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access Commission MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced today that Acentra Health Executive Vice President and Chief Strategy Officer Verlon Johnson, MPA, has been appoint
